Honouring Dr. Murray B. Urowitz: A Legacy of Lupus Research

March 21, 2024 – Lupus Canada is honoured to support the Dr. Murray B. Urowitz Chair in Lupus Research. For over 50 years, Dr. Murray Urowitz led the world in lupus diagnosis, treatment, research and education. The Dr. Murray B. Urowitz Chair in Lupus Research...

Anifrolumab (Saphnelo) listed in NS

March 6, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in Nova Scotia effective March 1, 2024. The public notice and listing criteria will appear on the Nova Scotia Pharmacare Programs website when the March Bulletin is...

Lupus and COVID-19

This is an anxious time across Canada and all over the world; keep in mind that most people who become infected have mild or even no symptoms. The main goal of all current recommendations is to slow the spread of the virus. People with lupus may ask: What precautions...